Under normal conditions, ATP and ADP cannot cross the inner mitochondrial membrane due to their high negative charges, but ATP/ADP translocase, an
The net process is denoted by:
ATP-ADP exchange is energetically expensive: about 25% of the energy yielded from electron transfer by aerobic respiration, or one hydrogen ion, is consumed to regenerate the membrane potential that is tapped by ATP/ADP translocase.[1]
In 1955, Siekevitz and PottercDNA of ATP/ADP translocase was sequenced for bovine in 1982[12] and a yeast species Saccharomyces cerevisiae in 1986[13] before finally Battini et al. sequenced a cDNA clone of the human transporter in 1989. The homology in the coding sequences between human and yeast ATP/ADP translocase was 47% while bovine and human sequences extended remarkable to 266 out of 297 residues, or 89.6%. In both cases, the most conserved residues lie in the ATP/ADP substrate binding pocket.[3]
Rare but severe diseases such as
ATP/ADP translocase is very specifically inhibited by two families of inhibitors. The first family, which includes atractyloside (ATR) and carboxyatractyloside (CATR), binds to the ATP/ADP translocase from the matrix in lieu of ATP, causing eversion but keeping the translocase in the conformation facing the cytoplasm. In contrast, the second family, which includes
{{cite book}}
{{cite journal}}
|coauthors=
|author=
|date=
Category:Cellular respiration